Orchard Therapeutics plc - ADR

NASDAQ:ORTX   3:59:44 PM EDT
4.77
+0.22 (+4.84%)
Products

Orchard Therapeutics Announces FDA Clearance Of IND Application For OTL-200 For Metachromatic Leukodystrophy

Published: 11/19/2020 12:39 GMT
Orchard Therapeutics PLC (ORTX) - Orchard Therapeutics Announces FDA Clearance of Ind Application for Otl-200 for Metachromatic Leukodystrophy (mld).
Orchard Therapeutics Plc - Co Has Applied for Rmat Designation for Otl-200 to Help Facilitate Additional Dialogue With FDA.